Blood pressure reduction and treatment with renin-angiotensin-aldosterone system blockers or immunosuppressant [39] have been advocated to slow the CKD progression although the use of the latter remains controversial with conflicting evidence [40]. The gene discussed is REN; the disease is chronic kidney disease.